BB BIOTECH AG Interim Report as at 30.06.2022
Table of contents
Business Report | 3-13 |
Performance/Multi-year comparison | 3 |
Shareholder letter | 8 |
Portfolio at a glance | 13 |
Financial Report | 14-26 |
Consolidated interim financial statements | 14 |
Selected explanatory notes to the consolidated interim financial statements | 18 |
Report of the statutory auditors | 26 |
About us | 27-44 |
Company Profile | 27 |
Investment strategy | 28 |
Investment process | 30 |
Board of Directors | 32 |
Investment Manager | 36 |
Shareholder information | 40 |
Facts & figures | 41 |
Corporate calendar | 42 |
Contact | 43 |
3 | Business Report - Performance |
Performance/Multi-year comparison
BB Biotech Interim report as at 30.06.2022
4Business Report - Performance
Indexed performance since launch
BB Biotech AG (SIX)-CHF
0
NAV CHF indexed Share Price CHF indexed Nasdaq Biotech Index (NBI) TR indexed
Rolling performance | Annual performance | ||||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | ||||
30.06.2021 - 30.06.2022 | (31.2%) | (32.4%) | (24.3%) | 2021 | 8.3% | (11.5%) | 3.0% | ||
30.06.2020 - 30.06.2021 | 30.9% | 17.0% | 17.8% | 2020 | 19.3% | 24.3% | 15.8% | ||
28.06.2019 - 30.06.2020 | 11.7% | 20.1% | 22.3% | 2019 | 18.5% | 23.4% | 23.0% | ||
29.06.2018 - 28.06.2019 | 3.5% | 4.1% | (1.7%) | 2018 | (5.2%) | (14.5%) | (8.0%) | ||
30.06.2017 - 29.06.2018 | 18.8% | 3.8% | 10.6% | 2017 | 22.9% | 23.4% | 16.4% | ||
Cumulated performance | Annualized performance | ||||||||
30.06.2022 | 30.06.2022 | ||||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | ||||
YTD | (22.4%) | (16.8%) | (16.6%) | 1 year | (31.2%) | (32.4%) | (24.3%) | ||
1 year | (31.2%) | (32.4%) | (24.3%) | 3 years | 0.2% | (1.7%) | 2.9% | ||
3 years | 0.7% | (5.0%) | 9.0% | 5 years | 4.4% | 0.5% | 3.4% | ||
5 years | 23.8% | 2.7% | 18.4% | since inception 1) | 11.9% | 11.0% | 9.2% | ||
since inception 1) | 2 380% | 1 878% | 1 148% | 1 | 09.11.1993 | ||||
1 | 09.11.1993 |
BB Biotech Interim report as at 30.06.2022
5 | Business Report - Performance |
BB BIOTECH AG (XETRA)-EUR
0
NAV EUR indexed Share Price EUR indexed Nasdaq Biotech Index (NBI) TR indexed
Rolling performance | Annual performance | ||||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | ||||
30.06.2021 - 30.06.2022 | (23.9%) | (25.9%) | (17.0%) | 2021 | 13.3% | (7.8%) | 7.4% | ||
30.06.2020 - 30.06.2021 | 26.5% | 13.5% | 14.4% | 2020 | 18.1% | 24.8% | 16.1% | ||
28.06.2019 - 30.06.2020 | 17.0% | 25.3% | 27.4% | 2019 | 23.4% | 28.1% | 27.6% | ||
29.06.2018 - 28.06.2019 | 8.1% | 8.5% | 2.6% | 2018 | (2.2%) | (11.1%) | (4.3%) | ||
30.06.2017 - 29.06.2018 | 12.3% | (1.8%) | 4.5% | 2017 | 12.9% | 12.5% | 6.7% | ||
Cumulated performance | Annualized performance | ||||||||
30.06.2022 | 30.06.2022 | ||||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | ||||
YTD | (18.6%) | (13.8%) | (13.4%) | 1 year | (23.9%) | (25.9%) | (17.0%) | ||
1 year | (23.9%) | (25.9%) | (17.0%) | 3 years | 4.0% | 1.7% | 6.5% | ||
3 years | 12.6% | 5.4% | 21.0% | 5 years | 6.5% | 2.3% | 5.3% | ||
5 years | 36.7% | 12.3% | 29.7% | since inception 1) | 13.3% | 12.3% | 11.2% | ||
since inception 1) | 2 063% | 1 615% | 1 262% | 1 | 10.12.1997 | ||||
1 | 10.12.1997 |
BB Biotech Interim report as at 30.06.2022
Questo è un estratto del contenuto originale. Per continuare a leggere, accedi al documento originale.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BB Biotech AG published this content on 22 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 July 2022 04:33:00 UTC.
